コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 osis (previously known as human granulocytic ehrlichiosis).
2 an anaplasmosis (formerly human granulocytic ehrlichiosis).
3 ar rickettsial agent, causes human monocytic ehrlichiosis.
4 rlichia canis, the etiologic agent of canine ehrlichiosis.
5 tic bacterium that causes human granulocytic ehrlichiosis.
6 cytophila an etiologic agent of granulocytic ehrlichiosis.
7 m of granulocytes, causes human granulocytic ehrlichiosis.
8 en for the serodiagnosis of canine monocytic ehrlichiosis.
9 vaccine candidate immunogenic against canine ehrlichiosis.
10 organism, causes the disease human monocytic ehrlichiosis.
11 evelopment of a vector transmission model of ehrlichiosis.
12 se of murine Lyme arthritis and granulocytic ehrlichiosis.
13 ion in the serodiagnosis of canine monocytic ehrlichiosis.
14 agocytophila, an agent of human granulocytic ehrlichiosis.
15 tes and macrophages, causes canine monocytic ehrlichiosis.
16 ng human diseases monocytic and granulocytic ehrlichiosis.
17 llular bacterium that causes human monocytic ehrlichiosis.
18 ul for serodiagnosis of human monocytotropic ehrlichiosis.
19 tial antigen for the serodiagnosis of canine ehrlichiosis.
20 ransmits Lyme disease and human granulocytic ehrlichiosis.
21 with convalescent sera from dogs with canine ehrlichiosis.
22 gen for the serodiagnosis of human monocytic ehrlichiosis.
23 tion in the serodiagnosis of human monocytic ehrlichiosis.
24 ion of cytokines and chemokines during fatal ehrlichiosis.
25 and rapid serodiagnosis for human monocytic ehrlichiosis.
26 ntibodies to the agent of human granulocytic ehrlichiosis.
27 affeensis or the agent of human granulocytic ehrlichiosis.
28 sepsis using murine models of mild and fatal ehrlichiosis.
29 . canis, and the agent of human granulocytic ehrlichiosis.
30 affeensis or the agent of human granulocytic ehrlichiosis.
31 sulting in disease manifestations that mimic ehrlichiosis.
32 tection is not afforded against granulocytic ehrlichiosis.
33 entations compatible with human granulocytic ehrlichiosis.
34 tsu is the causative agent of human Sennetsu ehrlichiosis.
35 s, is the etiologic agent of human monocytic ehrlichiosis.
36 nsistent, and rapid serodiagnosis for canine ehrlichiosis.
37 y and toxic shock in a murine model of fatal ehrlichiosis.
38 substrate for identifying human granulocytic ehrlichiosis.
39 ly for the diagnosis of human monocytotropic ehrlichiosis.
40 ted from a patient from Oklahoma with severe ehrlichiosis.
41 sible for both equine and human granulocytic ehrlichiosis.
42 llular bacterium that causes human monocytic ehrlichiosis.
43 dual with prior confirmed human granulocytic ehrlichiosis.
44 NA in blood samples from human patients with ehrlichiosis.
45 ed with babesiosis was also seropositive for ehrlichiosis.
46 biting clinical signs compatible with canine ehrlichiosis.
47 t variables in experimentally induced canine ehrlichiosis.
48 nd is the etiologic agent of human monocytic ehrlichiosis.
49 diagnose and ascertain the cause of cases of ehrlichiosis.
50 llular bacterium that causes human monocytic ehrlichiosis.
51 s clinical outcome for patients suspected of ehrlichiosis.
52 another laboratory tool for the diagnosis of ehrlichiosis.
53 of pathogenic immune responses during fatal ehrlichiosis.
54 l, is the causative agent of human monocytic ehrlichiosis.
55 ick-borne causative agent of human monocytic ehrlichiosis.
56 the most recently recognized agent of human ehrlichiosis.
57 ne bacterium responsible for human monocytic ehrlichiosis.
58 d with tick-transmitted human monocytotropic ehrlichiosis.
59 ent of globally distributed canine monocytic ehrlichiosis.
60 s during the acute phase of canine monocytic ehrlichiosis.
61 hrlichia muris mouse model of monocytotropic ehrlichiosis.
62 ent, causes human monocyte/macrophage-tropic ehrlichiosis.
63 mbles the fatal form of human monocytotropic ehrlichiosis.
64 on, which contribute to development of fatal ehrlichiosis.
65 a phagocytophilum, the agent of granulocytic ehrlichiosis.
66 philum causes the disease human granulocytic ehrlichiosis.
67 gated the signals that activate HSPCs during ehrlichiosis, a disease characterized by profound hemato
69 ed strain of the agent of human granulocytic ehrlichiosis, a recently described emerging rickettsial
70 n monocytic ehrlichiosis; human granulocytic ehrlichiosis; a novel cat flea-associated typhus group r
73 repeat units of the human granulocytotropic ehrlichiosis agent 130-kDa protein and of the fimbria-as
74 ribes the kinetics of the human granulocytic ehrlichiosis agent in the blood of horses experimentally
75 ia equi in horses and two human granulocytic ehrlichiosis agent isolates in California for sequence d
76 of Ehrlichia equi or the human granulocytic ehrlichiosis agent to assess the suitability of differen
77 Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) are encoded by the p44 multigene fam
83 le antibodies against the human granulocytic ehrlichiosis agent; however, only 2 had a 4-fold antibod
84 n together, these results suggest that human ehrlichiosis agents became cholesterol dependent due to
85 To understand whether human monocytotropic ehrlichiosis also occurs in this northeastern geographic
86 aackii), increases human risk of exposure to ehrlichiosis, an emerging infectious disease caused by b
92 dren with clinical signs suggestive of human ehrlichiosis and 43 apparently healthy adults who had a
93 nostic and vaccine antigens for granulocytic ehrlichiosis and aid in the classification of genogroup
94 a useful method for early detection of human ehrlichiosis and determination of etiology when serologi
95 in sera both from patients with granulocytic ehrlichiosis and from patients with monocytotropic ehrli
97 rate for the detection of human granulocytic ehrlichiosis and should be used solely for the diagnosis
98 ma phagocytophilum causes human granulocytic ehrlichiosis and specifically infects and multiplies in
99 an anaplasmosis (formerly human granulocytic ehrlichiosis) and human monocytic ehrlichiosis (HME) are
100 d samples from seven patients with monocytic ehrlichiosis, and Amblyomma americanum ticks collected i
101 b typhus (caused by Orientia tsutsugamushi), ehrlichiosis, and anaplasmosis often present as undiffer
102 r, borreliosis, anaplasmosis, rickettsiosis, ehrlichiosis, and babesiosis are zoonotic and have been
103 tickborne infectious diseases (Lyme disease, ehrlichiosis, and babesiosis) was conducted among 230 re
104 p44 gene of the agent of human granulocytic ehrlichiosis (aoHGE) encodes a 44-kDa major outer surfac
106 kinetics of the agent of human granulocytic ehrlichiosis (aoHGE) were examined after needle and tick
109 naling promotes host susceptibility to fatal ehrlichiosis, because it mediates ehrlichia-induced immu
110 ither dog had clinical signs attributable to ehrlichiosis, both dogs were anemic and neutropenic and
111 nsis, the causative agent of human monocytic ehrlichiosis, but natural infection in deer has not been
112 d leukocytes from 413 patients with possible ehrlichiosis by broad-range and species-specific polymer
113 assays for the diagnosis of canine monocytic ehrlichiosis by comparing them to the indirect fluoresce
114 gents of Lyme disease and human granulocytic ehrlichiosis by individual ticks was equally efficient a
115 nsis, the etiologic agent of human monocytic ehrlichiosis, can cause hepatitis of various levels of s
116 ly with serum antibodies from suspect canine ehrlichiosis cases that were positive for E. canis by im
117 udy, we used a model of fatal monocytotropic ehrlichiosis caused by Ehrlichia bacteria from Ixodes ov
120 y to Ehrlichia and the pathogenesis of fatal ehrlichiosis caused by infection with low- and high-dose
121 in severe disease in a mouse model of fatal ehrlichiosis caused by Ixodes ovatus Ehrlichia (IOE).
123 ues by using murine models of mild and fatal ehrlichiosis caused by related monocytotropic Ehrlichia
125 s with confirmed or probable human monocytic ehrlichiosis due to E. chaffeensis also had antibodies t
126 Immune responses against monocytotropic ehrlichiosis during infection with a strain of Ehrlichia
127 Borrelia burgdorferi) and human granulocytic ehrlichiosis (Ehrlichia phagocytophila) are both transmi
128 a, including the agent of human granulocytic ehrlichiosis, Ehrlichia phagocytophila, and the bovine p
129 llular bacterium that causes human monocytic ehrlichiosis, encodes a single protein that contains a G
130 ed to correctly diagnose most cases of human ehrlichiosis, especially in geographic regions where bot
131 osely resemble those of human monocytotropic ehrlichiosis for which it is a promising model for inves
132 om patients who were clinically suspected of ehrlichiosis from 1 May to 1 August 2008 at Vanderbilt U
136 1(-/-) mice were highly susceptible to fatal ehrlichiosis, had overwhelming infection, and developed
138 n isolate of the agent of human granulocytic ehrlichiosis (HGE agent) from infected mice to larval ti
139 lot analyses containing a human granulocytic ehrlichiosis (HGE) agent (NCH-1 strain) were used to con
140 f A. phagocytophilum, the human granulocytic ehrlichiosis (HGE) agent and a variant (AP-Variant 1) th
141 a cultured isolate of the human granulocytic ehrlichiosis (HGE) agent by using an indirect immunofluo
142 ure isolate (USG3) of the human granulocytic ehrlichiosis (HGE) agent has identified a number of immu
145 r membrane protein of the human granulocytic ehrlichiosis (HGE) agent is an immunodominant antigen in
146 and macrophages, and the human granulocytic ehrlichiosis (HGE) agent is an obligatory intracellular
147 rin (n = 1) counties, and human granulocytic ehrlichiosis (HGE) agent isolates were obtained from Hum
149 rRNA gene, the DNA of the human granulocytic ehrlichiosis (HGE) agent was detected in 17 of 47 mice (
152 ne proteins (OMPs) of the human granulocytic ehrlichiosis (HGE) agent, with molecular sizes of 44 to
155 tophila, and the agent of human granulocytic ehrlichiosis (HGE) amplified DNA from extracts of these
156 od for early detection of human granulocytic ehrlichiosis (HGE) and determination of etiology when se
157 blood from patients with human granulocytic ehrlichiosis (HGE) and from infected HL60 cell cultures.
158 response in patients with human granulocytic ehrlichiosis (HGE) and in mice infected with the HGE age
160 servoirs for the agent of human granulocytic ehrlichiosis (HGE) are suspected to be the small mammals
162 were suspected of having human granulocytic ehrlichiosis (HGE) but who lacked antibodies to ehrlichi
163 ank gene of the agent of human granulocytic ehrlichiosis (HGE) codes for a protein with a predicted
164 the sera of patients with human granulocytic ehrlichiosis (HGE) commonly recognize a 44-kDa antigen.
165 lated from a patient with human granulocytic ehrlichiosis (HGE) developed anemia and leukopenia, but
180 The etiologic agent of human granulocytic ehrlichiosis (HGE) is an obligate intracellular bacteriu
184 tic ehrlichiosis (HME) or human granulocytic ehrlichiosis (HGE) may be made on the basis of serologic
187 nfected with the agent of human granulocytic ehrlichiosis (HGE) to evaluate the importance of these p
188 response to the agent of human granulocytic ehrlichiosis (HGE) was assessed in a murine infection mo
189 nsmission of the agent of human granulocytic ehrlichiosis (HGE) was determined by removing feeding ti
191 s containing the agent of Human Granulocytic Ehrlichiosis (HGE) was studied to investigate how this p
192 m patients with confirmed human granulocytic ehrlichiosis (HGE) were tested for cytoplasmic, nuclear,
193 p44 genes of the agent of human granulocytic ehrlichiosis (HGE) with primers flanking the hypervariab
194 a murine model system of human granulocytic ehrlichiosis (HGE), C3H/HeJ, C3H-SCID, and Peromyscus le
195 gocytophila, the agent of human granulocytic ehrlichiosis (HGE), Ehrlichia canis, Bartonella henselae
198 gocytophila, the agent of human granulocytic ehrlichiosis (HGE), in different groups of adults and ch
208 anulocytic ehrlichiosis) and human monocytic ehrlichiosis (HME) are emerging tick-borne infections ca
209 nine culture-proven cases of human monocytic ehrlichiosis (HME) caused by Ehrlichia chaffeensis.
210 s, rheumatoid arthritis, and human monocytic ehrlichiosis (HME) did not react with HGE-44-MBP antigen
212 We report the second case of human monocytic ehrlichiosis (HME) in a liver transplant recipient, and
216 that incorrect diagnoses of human monocytic ehrlichiosis (HME) or human granulocytic ehrlichiosis (H
217 ection, can be classified as human monocytic ehrlichiosis (HME) or human granulocytic ehrlichiosis (H
218 and causes potentially fatal human monocytic ehrlichiosis (HME) that mimics toxic-shock-like syndrome
220 ia chaffeensis, the agent of human monocytic ehrlichiosis (HME), Babesia microti, and Borrelia burgdo
221 nsis, the etiologic agent of human monocytic ehrlichiosis (HME), has been extensively studied as a ca
222 eptibility and resistance to human monocytic ehrlichiosis (HME), immunocompetent and immunocompromise
227 llular bacterium that causes human monocytic ehrlichiosis (HME): a febrile illness that may progress
228 ythema migrans-like illness; human monocytic ehrlichiosis; human granulocytic ehrlichiosis; a novel c
229 e found at sites where cases of granulocytic ehrlichiosis in a horse and a llama had recently occurre
231 5 patients diagnosed with human granulocytic ehrlichiosis in Connecticut were tested by indirect IFA
236 identical to the agent of human granulocytic ehrlichiosis in Minnesota and Wisconsin and to be very s
237 lecular evidence indicates that granulocytic ehrlichiosis in Minnesota and Wisconsin dogs is not caus
240 is the predominant etiologic agent of canine ehrlichiosis in the areas of Missouri included in this s
241 Department of Health for human granulocytic ehrlichiosis in the residents of Westchester County, N.Y
243 ies in a mouse model of human monocytotropic ehrlichiosis indicated that CD8 T cells are not essentia
256 Ehrlichia chaffeensis and human granulocytic ehrlichiosis is caused by an agent similar to Ehrlichia
261 a, the etiologic agent of human granulocytic ehrlichiosis, is an emerging bacterial pathogen that inv
262 tein of Ehrlichia canis, the agent of canine ehrlichiosis, is the major antigen recognized by both na
263 nsis, the causative agent of human monocytic ehrlichiosis, is transmitted by Amblyomma americanum tic
264 are intracellular bacteria that cause fatal ehrlichiosis, mimicking toxic shock syndrome in humans a
265 p., p44 from the agent of human granulocytic ehrlichiosis, msp-2 and msp-4 from Anaplasma marginale,
269 ve in peripheral blood leukocytes from human ehrlichiosis patients and experimentally infected animal
271 ae, the causative agents of anaplasmosis and ehrlichiosis, persist in the bloodstream of their mammal
272 newly identified tick-borne diseases such as ehrlichiosis raise additional questions about the role o
274 rent antibody testing for human granulocytic ehrlichiosis relies predominantly on indirect fluorescen
275 st, the risk of acquiring human granulocytic ehrlichiosis remains minimal despite the abundance of ap
276 nsis, the etiologic agent of human monocytic ehrlichiosis, replicates in early endosomes by avoiding
278 m, the causative agent of human granulocytic ehrlichiosis, results in downregulation of the gp91(phox
281 d ticks with the agent of human granulocytic ehrlichiosis, suggesting that these rodents serve as res
283 ve used a newly described model of monocytic ehrlichiosis that results from infection of mice by an e
284 suitable antigen for serodiagnosis of canine ehrlichiosis, the immunoreactions between rP30 and the w
285 ma phagocytophilum causes human granulocytic ehrlichiosis, the second most common tick-borne disease
286 m patients with confirmed human granulocytic ehrlichiosis (three from New York, four from Wisconsin,
287 tand these changes, we used a mouse model of ehrlichiosis to determine whether the observed hematolog
289 The causative agent of human granulocytic ehrlichiosis was recently reclassified as Anaplasma phag
290 gocytophila (the agent of human granulocytic ehrlichiosis), was evaluated by class-specific enzyme-li
292 s of susceptibility to severe monocytotropic ehrlichiosis, we compared low and high doses of the high
295 rom dogs with clinical signs compatible with ehrlichiosis were examined for infection of Ehrlichia ca
296 tologic abnormalities associated with canine ehrlichiosis were tested by IFA assay and by recombinant
297 r complete protection against monocytotropic ehrlichiosis, which is associated with a strong cell-med
298 igated as a more appropriate model of canine ehrlichiosis, which is naturally transmitted by arthropo
300 this study was to develop a mouse model for ehrlichiosis with the newly discovered human pathogen, E